Thanks to our innovative vision and translational approach, Cardiomedex is your partner of choice for:
- Optimizing processes to enable early clinical proof of concept
- Therapeutic switching or re-profiling
- Extending drug life cycles
- Developing intellectual property rights for compounds
Strategic reprofiling of an antihypertensive drug inhibiting renin-angiotensin-aldosteron system.
The clinical development of this compound in the cardiovascular field provided epidemiologic results from which our team highlighted neuro-protective effects. Our action then led to the repositioning of this drug in the treatment of dementia.
Our team of highly skilled physicians and scientists provide value-added and strategic consulting solutions. We adopt a personalized approach to maximize your research productivity and streamline drug development, repositioning and lifecycle extension management.
Our services include:
- Personalized collaboration to develop an optimal and efficient early phase clinical research strategy as well as repositioning plan
- Customized study design and protocol development to meet your business objectives
- Extensive clinical pharmacology expertise, networks and scientific experience
- Expert reporting skills
- Medical writing expertise
- Support of pre-regulatory and regulatory submissions (ANSM / AFSSAPS, HAS, EMEA, FDA)